Physician profile
Heidi A Schultz
NPI 1275506719
$1,227.91
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,068 · 2020: $137 · 2024: $22.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $22.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $22.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $176.27 | 2019-2020 | |
| Novo Nordisk INC | $174.13 | 2019-2020 | |
| Amarin Pharma, INC. | $114.67 | 2019 | |
| Astellas Pharma US INC | $109.96 | 2019 | |
| Sanofi-Aventis U.S. LLC | $109.58 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $63.77 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.57 | 2019 | |
| Pfizer INC. | $55.10 | 2019-2020 | |
| Lilly USA, LLC | $52.20 | 2019 | |
| Allergan, INC. | $41.26 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $35.64 | 2019 | |
| Shire North American Group INC | $34.80 | 2019 | |
| Merck Sharp & Dohme LLC | $33.20 | 2019 | |
| Janssen Pharmaceuticals, INC | $32.81 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.30 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22.98 | 2024 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.16 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.73 | 2019 | |
| Amgen INC. | $14.69 | 2019 | |
| Glaxosmithkline, LLC. | $14.18 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.46 | 2019 | |
| Cranial Technologies, INC | $11.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.